Literature DB >> 33560441

Targeting phospholipid metabolism for glioblastoma therapy.

Tianzhi Huang1, Shi-Yuan Cheng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33560441      PMCID： PMC7992890          DOI： 10.1093/neuonc/noaa309

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

1.  Impaired contractility and detrusor hypertrophy in cavin-1-deficient mice.

Authors:  Mardjaneh Sadegh Karbalaei; Catarina Rippe; Sebastian Albinsson; Mari Ekman; Alva Mansten; Bengt Uvelius; Karl Swärd
Journal:  Eur J Pharmacol       Date:  2012-05-27       Impact factor: 4.432

2.  Proteomic identification of a marker signature for MAPKi resistance in melanoma.

Authors:  Verena Paulitschke; Ossia Eichhoff; Christopher Gerner; Philipp Paulitschke; Andrea Bileck; Thomas Mohr; Phil F Cheng; Alexander Leitner; Emmanuella Guenova; Ieva Saulite; Sandra N Freiberger; Anja Irmisch; Bernhard Knapp; Nina Zila; Theodora-Pagona Chatziisaak; Jürgen Stephan; Joanna Mangana; Rainer Kunstfeld; Hubert Pehamberger; Ruedi Aebersold; Reinhard Dummer; Mitchell P Levesque
Journal:  EMBO J       Date:  2019-06-26       Impact factor: 11.598

3.  Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood.

Authors:  Nobuyuki Murakami; Yukiko K Hayashi; Yuji Oto; Masahisa Shiraishi; Hisashi Itabashi; Kyoko Kudo; Ichizo Nishino; Ikuya Nonaka; Toshiro Nagai
Journal:  Neuromuscul Disord       Date:  2013-03-13       Impact factor: 4.296

4.  Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.

Authors:  Libin Liu; Dennis Brown; Mary McKee; Nathan K Lebrasseur; Dan Yang; Kenneth H Albrecht; Katya Ravid; Paul F Pilch
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

5.  PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.

Authors:  Kaikai Yi; Qi Zhan; Qixue Wang; Yanli Tan; Chuan Fang; Yunfei Wang; Junhu Zhou; Chao Yang; Yansheng Li; Chunsheng Kang
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

6.  Expression of Cytosolic Phospholipase A2 Alpha in Glioblastoma Is Associated With Resistance to Chemotherapy.

Authors:  Lei Yang; Haiyan Zhang
Journal:  Am J Med Sci       Date:  2018-06-25       Impact factor: 2.378

Review 7.  Targeting Phospholipid Metabolism in Cancer.

Authors:  Menglin Cheng; Zaver M Bhujwalla; Kristine Glunde
Journal:  Front Oncol       Date:  2016-12-27       Impact factor: 6.244

Review 8.  Recent advances in cancer metabolism: a technological perspective.

Authors:  Yun Pyo Kang; Nathan P Ward; Gina M DeNicola
Journal:  Exp Mol Med       Date:  2018-04-16       Impact factor: 8.718

9.  Mapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during Activation.

Authors:  David A Slatter; Maceler Aldrovandi; Anne O'Connor; Stuart M Allen; Christopher J Brasher; Robert C Murphy; Sven Mecklemann; Saranya Ravi; Victor Darley-Usmar; Valerie B O'Donnell
Journal:  Cell Metab       Date:  2016-04-28       Impact factor: 27.287

10.  The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.

Authors:  Kai Huang; Chuan Fang; Kaikai Yi; Xing Liu; Hongzhao Qi; Yanli Tan; Junhu Zhou; Ying Li; Mingyang Liu; Yuqing Zhang; Jingxuan Yang; Jianning Zhang; Min Li; Chunsheng Kang
Journal:  Theranostics       Date:  2018-02-07       Impact factor: 11.556
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.